Disitamab Vedotin Combined With SOX Regimen Versus SOX Alone as Adjuvant Therapy for HER2-Moderate/High Expressing Stage Ⅲ Gastric Cancer: A Prospective, Multicenter, Randomized, Phase Ⅱ Clinical Trial
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to GC/GEJC
Related studies linked through entity extraction aliases.
Mecapegfilgrastim Combined With Adebrelimab and Chemotherapy as Neoadjuvant Therapy in Resectable GC/GEJC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC)
- Status
- RECRUITING
- Phase
- PHASE2